Lumen-apposing metal stent (LAMS) and double-pigtail plastic stent (DPPS)

DEVICE4 trials

Sponsors

Hospital Universitari de Bellvitge

Conditions

Biliary Tract NeoplasmsMalignant Biliary ObstructionPancreatic CancerPancreatic Cancer Non-resectablePancreatic Cancer Resectable

Unknown Phase

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Not yet recruitingNCT06375954

Hospital Universitari de BellvitgeBiliary Tract Neoplasms, Malignant Biliary Obstruction, Pancreatic Cancer

Start: 2024-05-01End: 2027-05-01Target: 96Updated: 2024-04-19

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

Not yet recruitingNCT06375928

Hospital Universitari de BellvitgeBiliary Tract Neoplasms, Malignant Biliary Obstruction, Pancreatic Cancer Resectable

Start: 2024-05-01End: 2026-05-01Target: 44Updated: 2024-04-19

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

SuspendedNCT06375967

Hospital Universitari de BellvitgeBiliary Tract Neoplasms, Malignant Biliary Obstruction, Pancreatic Cancer Non-resectable

Start: 2024-10-18End: 2027-10-01Target: 128Updated: 2026-05-06

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

SuspendedNCT06653192

Hospital Universitari de BellvitgeBiliary Tract Neoplasms, Malignant Biliary Obstruction, Pancreatic Cancer

Start: 2025-05-06End: 2028-05-06Target: 120Updated: 2026-05-06